Interesting. So, on that logic, Scneario2 is less likely in the near future. Or, JC simply needed some quick money for whatever reasons.
Do you know, if we are waiting for any other animal data, before formalizing chats regarding carfilzomib(Amgen, J&J)?
Licensing/partnership discussions might take more than a few months to eventuate after either party approaches another for discussions.
@Mason14, speculated previously partnership was likely by June this year.
Anyways, would be nice to receive this quarter's news first.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.000(0.00%) |
Mkt cap ! $199.8M | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.16 | $1.13 | $64.86K | 56.66K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2698 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 1493 | 1 |
View Market Depth
| Last trade - 16.10pm 21/07/2025 (20 minute delay) ? |
| RAC (ASX) Chart |